1. To appreciate the presence of marked genomic heterogeneity in gastric and esophageal cancer
  2. To consider potential roles of cfDNA profiling in guiding therapy in gastroesophageal cancer
  3. To consider emerging therapeutic approaches for tumors with KRAS amplification
Session date: 
08/20/2018 - 12:00pm to 1:00pm CDT
900 East 57th Street
Conference Room 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Adam J. Bass, MD